Prevalence, patterns and outcomes of cardiac involvement in Erdheim–Chester disease
Authors:
- Lévi-Dan AzoulayLALévi-Dan Azoulay
- Fleur Cohen-AubartFCFleur Cohen-Aubart
- Jean-François EmileJEJean-François Emile
- Danielle SeilheanDSDanielle Seilhean
- Isabelle PluIPIsabelle Plu
- Frédéric CharlotteFCFrédéric Charlotte
- Xavier WaintraubXWXavier Waintraub
- Fabrice CarratFCFabrice Carrat
- Zahir AmouraZAZahir Amoura
- Philippe CluzelPCPhilippe Cluzel
- Julien HarocheJHJulien Haroche
- 21 December 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (26) , 2376-2385
Abstract
Cardiac involvement of Erdheim–Chester disease (ECD), a rare L group histiocytosis, has been reported to be associated with poor outcomes, but systematic studies are lacking. The present study aimed to investigate the prevalence, clinical features, imaging features, and prognosis of cardiac involvement in ECD in a large series. All patients with ECD who underwent cardiac magnetic resonance (CMR) imaging between 2003 and 2019 at a French tertiary center were retrospectively included. Primary outcome was all-cause mortality. Secondary outcomes were pericarditis, cardiac tamponade, conduction disorders, device implantation and coronary artery disease (CAD). A total of 200 patients were included [63 (54–71) years, 30% female, 58% BRAFV600E mutated]. Median follow-up was 5.5 years (3.3–9 years). On CMR, right atrioventricular sulcus infiltration was observed in 37% of patients, and pericardial effusion was seen in 24% of patients. In total, 8 patients (4%) had pericarditis (7 acute, 1 constrictive), 10 patients (5%) had cardiac tamponade, 5 patients (2.5%) had ECD-related high-degree conduction disorders, and 45 patients (23%) had CAD. Overall, cardiac involvement was present in 96 patients (48%) and was associated with BRAFV600E mutation [Odds ratio (OR) = 7.4, 95% confidence interval (CI) (3.5–16.8), P < 0.001] and ECD-related clinical events [OR = 5, 95%CI (1.5–21.2), P = 0.004] but not with lower survival in multivariate analysis [adjusted hazard ratio (HR) = 1.4, 95% CI (0.8–2.5), P = 0.2]. Cardiac involvement is present in nearly half of ECD patients and is associated with BRAFV600E mutation and complications (pericarditis, cardiac tamponade, and conduction disorders) but not with lower survival. More than half of ECD patients had evidence of cardiac involvement on CMR, which was associated with a higher risk of clinical events. Abbreviations: CMR cardiac magnetic resonance; ECD, Erdheim–Chester disease; HR, hazard ratio; OR, odds ratio.Keywords
This publication has 27 references indexed in Scilit:
- Constrictive pericarditis in Erdheim–Chester disease: An integrated echocardiographic and magnetic resonance approachInternational Journal of Cardiology, 2014
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationBlood, 2013
- Cardiac magnetic resonance characterization of atrial pseudo-mass in Erdheim-Chester diseaseEuropean Heart Journal, 2009
- Cardiac Involvement in Erdheim-Chester DiseaseCirculation, 2009
- Pericarditis Heralding Erdheim-Chester DiseaseCirculation, 2008
- Human epicardial adipose tissue: A reviewAmerican Heart Journal, 2007
- Cardiac involvement in systemic inflammatory diseasesEuropean Heart Journal, 2007
- Magnetic Resonance Imaging Guiding Pacemaker Implantation for Severe Sinus Node Dysfunction Due to Cardiac Involvement in Erdheim-Chester DiseaseCirculation, 2007
- Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heartNature Clinical Practice Cardiovascular Medicine, 2005
- Cardiovascular Involvement, an Overlooked Feature of Erdheim-Chester DiseaseMedicine, 2004